Investment Bank Upgrades Third Wave Stock on Strong Q3 Results

Nov 06, 2006

NEW YORK (GenomeWeb News) — Investment bank Caris & Company has upgraded Third Wave Technologies’ shares to “above average” from “average” after the company last week reported a 26-percent increase in third-quarter revenue and a 30-percent decline in net loss.

Breaking News

Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022
In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More
Vibrent Health, University of Maryland Medicine Partner for Population Health Initiative
Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows
Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features
Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Investment Bank Upgrades Third Wave Stock on Strong Q3 Results

Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022

In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More

Vibrent Health, University of Maryland Medicine Partner for Population Health Initiative

Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows

Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features

Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle

Tennessee's COVID-19 Sequencing

Sanction Violation Charges

Prenetics to Go Public Through SPAC

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle

Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger

Exact Sciences Stock Spikes After Primary Care Sales Team Nearly Doubles

Illumina Adds Seven Genomics Startups to Accelerator Program

Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows